Statins and hypercholesterolaemia: UK Standing Medical Advisory Committee guidelines

被引：10

作者：

Jones, AF

机构：

来源：

LANCET | 1997年 / 350卷 / 9085期

关键词：

D O I：

10.1016/S0140-6736(05)63818-4

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1174 / 1175

页数：2

共 8 条

[1]

[Anonymous], 1995, Diabetes, V44, P1249

[2]

COX DR, 1972, J R STAT SOC B, V34, P187

[3] A NEURAL-NETWORK MODEL FOR SURVIVAL-DATA [J].

FARAGGI, D ;

SIMON, R .

STATISTICS IN MEDICINE, 1995, 14 (01) :73-82

[4] SURVIVAL ANALYSIS AND NEURAL NETS [J].

LIESTOL, K ;

ANDERSEN, PK ;

ANDERSEN, U .

STATISTICS IN MEDICINE, 1994, 13 (12) :1189-1200

[5]

PEDERSEN TR, 1994, LANCET, V344, P1383

[6] Targeting lipid-lowering drug therapy for primary prevention of coronary disease: An updated Sheffield table [J].

Ramsay, LE ;

Haq, IU ;

Jackson, PR ;

Yeo, WW ;

Pickin, DM ;

Payne, JN .

LANCET, 1996, 348 (9024) :387-388

[7] The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels [J].

Sacks, FM ;

Pfeffer, MA ;

Moye, LA ;

Rouleau, JL ;

Rutherford, JD ;

Cole, TG ;

Brown, L ;

Warnica, JW ;

Arnold, JMO ;

Wun, CC ;

Davis, BR ;

Braunwald, E .

NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (14) :1001-1009

[8] PREVENTION OF CORONARY HEART-DISEASE WITH PRAVASTATIN IN MEN WITH HYPERCHOLESTEROLEMIA [J].

SHEPHERD, J ;

COBBE, SM ;

FORD, I ;

ISLES, CG ;

LORIMER, AR ;

MACFARLANE, PW ;

MCKILLOP, JH ;

PACKARD, CJ .

NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (20) :1301-1307

← 1 →